D. Marin, “Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia,” Seminars Hematology, Vol. 47, No. 4, 2010, pp. 312-318. doi:10.1053/j.seminhematol.2010.06.003

has been cited by the following article:

• TITLE: Diagnosis of Chronic Myeloid Leukemia Early in Pregnancy

  AUTHORS: Fabio Stagno, Paolo Vigneri, Massimo Poidomani, Stefania Stella, Alessandra Cupri, Michele Massimino, Livia Manzella, Francesco Di Raimondo

  KEYWORDS: Chronic Myeloid Leukemia, Pregnancy, Therapy, BCR-ABL

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.1 No.1, September 20, 2011

  ABSTRACT: Imatinib therapy has revolutionized the clinical course of Chronic Myeloid Leukemia. The unexpected prolonged survival raised several issues on the quality of life and on the possibility to parent childs.